News & Events

Press Releases

Show All

January 2013

January 17, 2013 Cellular Dynamics Announces the Production of Human iPSC Lines Under cGMP ConditionsDownload PDF

cGMP iPSC Lines Enable the Possible Use of iPSC-derived Human Cells within a Clinical Setting MADISON, WIS., January 17, 2013 –Cellular Dynamics International, Inc. (CDI), a leading commercial producer of human induced pluripotent stem cell (iPSC) lines and tissue cells for drug discovery and safety, today announced that it is producing human iPSC master cell…

January 3, 2013 Cellular Dynamics Announces Agreement with AstraZeneca on Use of iPSC-derived Human Cells in Drug Discovery ResearchDownload PDF

MADISON, WIS., Jan 3, 2013 –Cellular Dynamics International, Inc. (CDI) today announced a Center of Excellence agreement with AstraZeneca to accelerate the pace of drug discovery through the use of human induced pluripotent stem cell (iPSC) lines and tissue cells. iPSC technology, based on reprogramming adult cells from a simple blood sample or a skin…